Delivery Order SPE2DB25D3404-SPE2DB25FUNRS
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of Carvedilol ER 10 mg capsules (30-count packages) with a ceiling value of $5,976.74. This is a firm fixed price delivery order with an ultimate completion date of June 20, 2025, and represents a non-set-aside competitive award. The contractor's place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for Carvedilol ER 20 mg capsules (30-count) valued at $10,541.75. This firm fixed-price delivery order, with an ultimate completion date of September 16, 2025, represents a competitive award with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $4,914.09 to AmerisourceBergen Drug Corp for the supply of Carvedilol ER 20 mg capsules (30-count units) on June 25, 2025, with an ultimate completion date of June 26, 2025. This firm fixed-price, non-set-aside contract is performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $11,544.31 on August 29, 2025, for the supply of Carvedilol ER 20 mg capsules (30-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and a completion date of September 2, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $23,482.35 for Carvedilol ER 10 mg capsules (30-count packaging) on August 26, 2025, with an ultimate completion date of August 27, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded competitively under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX). AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a $4,710.22 delivery order to AmerisourceBergen Drug Corp for Carvedilol ER 80 mg capsules (30-count) on August 8, 2025, with an ultimate completion date of August 11, 2025. This firm fixed-price contract represents a non-set-aside, competitively awarded delivery order for pharmaceutical supply to support federal medical procurement needs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Carvedilol ER 10 mg capsules (30-count) under a firm fixed price contract valued at $1,358.25. The order was awarded on July 25, 2025, with an ultimate completion date of July 28, 2025. This non-set-aside competitive award reflects AmerisourceBergen's established role as a critical pharmaceutical supplier to federal medical procurement, with performance occurring at the company's corporate headquarters in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Carvedilol ER 20 mg capsules (30-count) at a firm fixed price of $1,846.89. This non-set-aside, competitively awarded contract represents a continuation of the company's extensive pharmaceutical supply relationship with DLA through its Medical Supply Chain. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Carvedilol ER 10 mg capsules (30-count units) with a ceiling value of $12,029.39. This firm fixed-price delivery order, which is not set-aside, represents a competitive award through AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026. The...
- The Defense Logistics Agency awarded a delivery order valued at $3,919.30 to AmerisourceBergen Drug Corp for Carvedilol ER 10 mg capsules (30-count units) on September 17, 2025, with an ultimate completion date of September 18, 2025. This firm fixed price, competitively awarded contract represents a non-set-aside procurement and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and...
- SPE2DB25D3404Indefinite Delivery Contract
- SPE2DB25D3404-SPE2DB25FUNRSDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $5,963.74 on June 3, 2025, for the supply of Carvedilol ER 10 mg capsules (30-count packages). This competitively awarded, firm fixed-price contract is non-set-aside and carries an ultimate completion date of June 4, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems through the DLA's Medical Supply Chain. This delivery order is issued under AmerisourceBergen's substantial Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle enables AmerisourceBergen to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company's federal contract portfolio demonstrates its capability to fulfill diverse medical supply requirements across multiple therapeutic domains, serving customers including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.0k | 6/3/25 |